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NeonatalRegulation of intramitochondrial free calcium ([Ca2+]m) is critical in both physiological and pathological
functioning of the heart. The full extent and importance of the role of [Ca2+]m is becoming apparent as
evidenced by the increasing interest and work in this area over the last two decades. However, controversies
remain, such as the existence of beat-to-beat mitochondrial Ca2+ transients; the role of [Ca2+]m in
modulating whole-cell Ca2+ signalling; whether or not an increase in [Ca2+]m is essential to couple ATP
supply and demand; and the role of [Ca2+]m in cell death by both necrosis and apoptosis, especially in
formation of the mitochondrial permeability transition pore. The role of [Ca2+]m in heart failure is an area
that has also recently been highlighted. [Ca2+]m can now be measured reasonably speciﬁcally in intact cells
and hearts thanks to developments in ﬂuorescent indicators and targeted proteins and more sensitive
imaging technology. This has revealed interactions of the mitochondrial Ca2+ transporters with those of the
sarcolemma and sarcoplasmic reticulum, and has gone a long way to bringing the mitochondrial Ca2+
transporters to the forefront of cardiac research. Mitochondrial Ca2+ uptake occurs via the ruthenium red
sensitive Ca2+ uniporter (mCU), and efﬂux via an Na+/Ca2+ exchanger (mNCX). The puriﬁcation and
cloning of the transporters, and development of more speciﬁc inhibitors, would produce a step-change in our
understanding of the role of these apparently critical but still elusive proteins. In this article we will
summarise the key physiological roles of [Ca2+]m in ATP production and cell Ca2+ signalling in both adult
and neonatal hearts, as well as highlighting some of the controversies in these areas. We will also brieﬂy
discuss recent ideas on the interactions of nitric oxide with [Ca2+]m.+44 117 3312168.
ifﬁths).
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Mitochondria were ﬁrst shown to be capable of taking up Ca2+ in
the 1960's [1,2], and the pathway for Ca2+ efﬂux was discovered by
Carafoli in 1974 as an Na+-dependent Ca2+ release mechanism in
isolated heart mitochondria[3]. With considerable insight, Carafoli
and Lehninger wrote in 1971: “…Ca2+ accumulation plays a general
and fundamental role in vertebrate cell physiology”[4]. It has taken us
almost forty years to begin to appreciate the full extent and
importance of this role.
Under physiological conditions in the heart the roles of intrami-
tochondrial free calcium ([Ca2+]m) include coupling of ATP supply and
demand by activation of the Ca2+-sensitive dehydrogenases [5] and
possibly the ATP synthase [6],modulatingwhole-cell Ca2+ signalling via
interactions with endo/sarcoplasmic reticulum Ca2+-release pathways
[7] and plasma membrane Ca2+ channels [8], and more recently
mitochondrial ﬁssion/fusion [9]. An increase in [Ca2+]m has been
associated with the transition from reversible to irreversible cell injury
in ischaemic/reperfused myocardium for many years [10], and we now
know that a major contributing factor to this injury is Ca2+-inducedopening of the mitochondrial permeability transition pore [11,12]. A
role for [Ca2+]m in heart failure, and for the mitochondrial Ca2+ efﬂux
pathway in the treatment of this condition has also been suggested
[13,14]. Ca2+ can activate nitric oxide synthase (NOS) under both
physiological and pathological conditions, which may impact on
mitochondrial function especially in view of the current albeit
controversial evidence for the existence of a mitochondrial form of
NOS (mNOS). In this review we will discuss the physiological roles of
[Ca2+]m, highlighting recent controversies. The role of [Ca2+]m in
ischaemia/reperfusion injury can be found in other recent reviews
[15,16].
2. Mitochondrial Ca2+ transport in the heart
2.1. Mitochondrial Ca2+ transport pathways
Mitochondria from all vertebrate sources tested can accumulate
Ca2+ in a respiration-dependent manner via the ruthenium red
(RuR)-sensitive Ca2+-uniporter (mCU). The Na+/Ca2+ exchanger
(mNCX) is themajor efﬂux pathway in the heart [3], although anNa+-
independent pathway exists in other tissues such as liver[17]. The
properties of these transporters were initially derived from studies on
isolated mitochondria (reviewed in [17,18]) and their kinetics
indicated that they were too slow to play any role in intracellular
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heart. These pathways are outlined in Fig. 1. The mCU exhibits low
afﬁnity, high capacity transport of Ca2+, whereas the mNCX has a
much lower Vmax, saturating at [Ca2+]m below 1 μM. The mNCX was
initially thought to be electroneutral [19], but later evidence pointed
to an electrogenic exchanger, of 3Na+:Ca2+[20,21]. A recent theoret-
ical model of the properties of the mNCX also found that 3:1
stoichiometry gave best ﬁt to available experimental data [22]. Thus
the stoichiometry of Na+/Ca2+ exchange is still in dispute.
It was predicted that net Ca2+ inﬂux would occur only when
external [Ca2+] rose above about 500 nM, which is much higher than
the resting, diastolic cytosolic free [Ca2+] ([Ca2+]c) of 100-200 nM
[23]. This, together with the sigmoidal nature of mitochondrial Ca2+
uptake (in presence of physiological [Mg2+]) suggested that the mCU
responded to a “weighted average” of cytosolic [Ca2+] ([Ca2+]c), so
systolic increases in [Ca2+]c (typically about 1 µM) would contribute
much more to mitochondrial Ca2+ uptake than diastolic [Ca2+]c [23].
Parallel measurements of [Ca2+]m and [Ca2+]c in rat myocytes
revealed that resting [Ca2+]m was about 80 nM compared with
resting [Ca2+]c of 150 nM whereas in mitochondria isolated from
beating hearts the [Ca2+]m was estimated to be slightly higher, about
170 nM [24]. In rat myocytes [Ca2+]m remained less than [Ca2+]c until
the latter rose above 500 nM [23] agreeing with studies on isolated
mitochondria [25]. However, a seminal paper by Rizzuto and Pozzan
in 1992 using aequorin targeted to mitochondria revealed that these
organelles were capable of taking up Ca2+ on a fast timescale, due to
their proximity to intracellular Ca2+ stores [26]. The ability of
mitochondria to respond to single fast cytosolic Ca2+ transients in
the heart is discussed in below.
A major step forward in research into control of [Ca2+]m would be
provided by knowing the molecular identity of the transporters.
However, although there have been a few sporadic attempts to purify
the transporters, they have yet to be fully puriﬁed or cloned (reviewed
in [27]).
2.2. Time-averaged integration of cytosolic Ca2+ transients or beat-to-
beat changes?
The question of whether mitochondrial Ca2+ transients exist
during normal excitation contraction coupling is still somewhatFig. 1. Ca2+ transport pathways in isolated mitochondria under physiological conditions.
Ca2+ inﬂux is via the Ca2+-uniporter (mCU), and Ca2+ efﬂux via the Na+/Ca2+ exchanger
(mNCX). The solid oval depicts the inner membrane and the dashed oval the permeable
outer membrane. Δψm – mitochondrial membrane potential, approximately -180 mV in
actively respiring mitochondria (inside negative).controversial, although a consensus seems to be slowly emerging. This
topic, together with methods of measuring [Ca2+]m in intact cells or
hearts has been covered in several recent reviews [7,28,29]. One
inescapable conclusion is that whether or not beat-to-beat changes
occur is species dependent[7]. For example, in a direct comparison
study, we found that mitochondrial Ca2+ transients could be detected
in guinea-pig but not rat cardiomyocytes [30]; see Fig. 2. It appears
that single transients do not occur in adult rat, mice, hamster, ferret or
cat cardiomyocytes, whereas mitochondrial Ca2+ transients can be
detected in neonatal rat, and adult guinea-pig and rabbit cardiomyo-
cytes (see [7] and references therein). In a recent study, changes in
[Ca2+]m during individual [Ca2+]c transients were found to occur in
adult rat myocytes, but thesewere very small, approximately 2-10 nM
[31], and they integrated gradually to a steady-state. This paper also
reported changes in mitochondrial Ca2+ uptake in response to
cytosolic Ca2+ waves, but which varied in mitochondria in different
parts of the cell; interﬁbrillar mitochondria giving a more consistent
rise than subsarcolemmal mitochondria [31].
We did observe beat-to-beat changes in [Ca2+]m in adult rat
myocytes using targeted aequorin [32], as opposed to our previous
results using indo-1, which showed no transients in these cells
[23,33]); however, this required high external [Ca2+] plus presence of
an adrenergic agonist, which may have pushed up [Ca2+]c to levels
capable of activating the mCU during a single systolic transient, and
which would not occur in absence of the agonist. The other difference
between the studies is that in order to express aequorin in
mitochondria, the cells had to be cultured for 2-3 days. It is known
that adult cells in culture start to de-differentiate, and eventually
revert back to a neonatal phenotype [34] although whether sufﬁcient
changes occurred over the short culture period we used (1-3 days) is
something we did not investigate.
The questions of how and why Ca2+ transport should differ
between species, or indeed during development from neonate to
adult, have not been addressed fully. It may be that the proximity of
mitochondrial Ca2+ transporters to Ca2+ channels of the SR or
sarcolemma are different between species, and/or that there are
populations of mitochondria with different Ca2+ transport properties.
One study found that in guinea-pig myocytes, Ca2+ transients
occurred in peripheral but not central mitochondria [35]. This is oneFig. 2.Mitochondrial Ca2+ transients in guinea-pig but not rat cardiomyocytes. [Ca2+]m
was measured in myocytes isolated from rat or guinea-pig hearts, and indo-1 loaded
under conditions that promote a mitochondrial localisation. Cells were stimulated to
beat at 0.2 Hz, and cell length monitored simultaneously with indo-1 ﬂuorescence.
Figure adapted from data ﬁrst presented in [30].
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between different populations of mitochondria in a single cell, and
could possibly be extrapolated to account for differences between
species.
As discussed above, the low afﬁnity of the mCU for Ca2+ may be
overcome by being juxtaposed to the SR ryanodine receptor (RyR),
although there is some evidence for other possible pathways of Ca2+
transport: A rapid uptake mode (RAM) has been proposed [36,37]
which, as its name suggests, is much faster than themCU. However, the
RAM was inactivated for over 1 min following a pulse of Ca2+, which
means that it could not take part in any rapid mitochondrial Ca2+
transients [37]. Neither is it obvioushow this pathway is reconciledwith
original studies on isolated mitochondria, indicating that, although the
mCU can take up large amounts of Ca2+, uptake is relatively slow. A
recent study in mitoplasts isolated from human myocytes provided
evidence for 2 distinct types of voltage-dependent Ca2+ uptake
pathways, differing in their sensitivity to Ru360. In mitoplasts from
failing hearts both channels showed reduced activity [38].
In guinea-pig cardiomyocytes, simultaneousmeasurement of [Ca2+]m
(using rhod-2) and [Ca2+]c (indo-1 dialysed into the cytosol), the
upstroke of the mitochondrial Ca2+ transient preceded that of the
cytosolic transient, whereas the decay lagged behind slightly [39]. Dialys-
ing Ru360 into the cells to inhibit mCU prevented the rise in [Ca2+]m, but
increased the amplitude of the cytosolic transient. Inhibiting mNCX with
CGP37157 caused an increase in [Ca2+]m, but also reduced the amplitude
of the cytosolic transient– aneffect ascribed to increasedbufferingof Ca2+
by the mitochondria [39]. Another explanation, however, is that the
mNCX contributes to SR reﬁlling following the action potential, and that
by preventing this pathway, there is less Ca2+ available for release upon
subsequent contractions. We also found a slightly reduced [Ca2+]c
transient in the presence of the mNCX inhibitor clonazepam [32], but
were unable to detect any changes in SR Ca2+ load, as measured by a
caffeine-induced transient. However, this method may not be the most
accurate, and it would be interesting to repeat the experiments using
probes targeted to the SR to more accurately measure [Ca2+] in this
compartment in presence of mNCX inhibitors.
The existence of a ryanodine receptor in the mitochondrial
membrane has also been proposed [40–42]; this appears to allow
rapid uptake of Ca2+ at relatively low concentrations, and so could
account for physiological beat-to-beat Ca2+ uptake. However, this
data relies on the purity of the mitochondrial preparation - which was
not speciﬁcally addressed in the studies [40,42]. We were unable to
detect presence of a RyR in puriﬁed heart mitochondria (Cheng and
Grifﬁths, unpublished data). This observation, plus work showing that
it is possible to obtain functional mitochondrial/SR membrane units
under certain isolation conditions [43], argues against the existence of
a mitochondrial RyR.
2.3. Modulation of myocyte Ca2+ signalling
Initial studies on non-cardiac cells found that mitochondria located
in close proximity to Ca2+-release channels on the endoplasmic
reticulum (ER) are exposed to a much higher level of [Ca2+] than
those elsewhere in the cytosol [26,44]. In these localised regions [Ca2+]c
has been estimated to be between 20-50 μM [45,46]. Evidence has
emerged over the last few years that such focal release of Ca2+ is also
likely to occur in the heart. Sharma et al. [45] found that in
skinned myocytes application of caffeine to the cells caused a large
release of Ca2+ from the SR that was taken up by mitochondria, as well
as entering the cytosol, and the mitochondrial uptake was inhibited by
RuR. Thus it is conceivable that mitochondria located in close proximity
to Ca2+ channels on the SR are exposed to amuch higher level of [Ca2+]
than those elsewhere in the cytosol [47] accounting for the ability of at
least a subpopulation of mitochondria to take up Ca2+ on a beat-to-beat
basis; this topic has been the subject of several recent reviews [7,27,48].
A recent paper found that inhibition SR Ca2+ handling by thapsigargin,tetracaine or caffeine prevented the progressive rise in [Ca2+]m in
response to [Ca2+]c waves, conﬁrming that Ca2+ released from the SR
was responsible for the rise in [Ca2+]m .Fig. 3 gives an outline of how
mitochondrial Ca2+ transporters may interact with those of the SR and
sarcolemma during excitation contraction coupling.
There is evidence that the mCU may also interact with L-type Ca2+
channels on the sarcolemma, andmay therefore play a role in controlling
Ca2+ ﬂuxes: Ru360 reduced the amplitude of cytosolic Ca2+ transients
when cells were stimulated at a frequency of 3 Hz, but not at 0.1 Hz
[8]. The authors suggested thatmitochondria played a role in sequestering
Ca2+, and so removed Ca2+ -dependent inactivation of L-type Ca2+
channels. However, another study found that in guinea-pig cardiomyo-
cytes Ru360 increased cytosolic Ca2+ transients at 10 nM, but caused a
decrease in the amplitude of [Ca2+]c at 100 nM [39].
There is now evidence for a direct physical coupling between
mitochondria and the SR that persists during isolation [43,49]):
mitochondrial fractions were obtained with associated SR compo-
nents, and these particles were highly resistant to further puriﬁcation
[43]. The “SR appendices” were capable of transferring Ca2+ directly
to mitochondria (measured with rhod-2 ﬂuorescence) upon stimu-
lation with caffeine, and of producing an increasing in the NADH
autoﬂuorescence signal, suggesting activation of the mitochondrial
dehydrogenases. This is the ﬁrst direct evidence that Ca2+ transfer
directly from the SR to mitochondria is capable of activating oxidative
metabolism [43].
A large proportion of sarcolemmal transporters are within the
transverse tubules (t-tubules) – about 50% of L-type Ca2+ channels
and themajority of the sarcolemmal Na+/Ca2+ exchanger (NCX) [50].
T-tubule membranes are located in close proximity (about 15 nm) to
the junctional cisterns of the SR, regions termed dyadic clefts.
Connections between the two have been observed by electron
microscopy – so-called “feet” - which are thought to be RyRs. A
recent study used electron tomography of mouse ventricular
myocytes to obtain a more detailed picture of the dyadic clefts, and
this also revealed electron dense structures – “bridges” - linking
mitochondrial outer membranes with SR or t-tubules, although there
were far fewer bridges between t-tubules and mitochondria than SR
andmitochondria [51]. The authors speculated thatmitochondria play
and additional role in preventing “catastrophic runaway Ca2+ release
in normal hearts” [51]. The identity of themitochondrial bridges is not
yet known.
Whereas there has been much work done in both non-cardiac and
now cardiac cell types on interactions of the SR and mCU, the
possibility of similar interactions with the SR and mNCX seems to
have been somewhat overlooked. However, there is evidence from
non-cardiac cells that this may occur: In HeLa cells challenged with
histamine (which releases Ca2+ from the ER via IP3 signalling) there
was a decline in [Ca2+]ER (measured with a targeted cameleon), but
this decline was greater in presence of the mNCX inhibitor CGP37157,
suggesting that efﬂux of Ca2+ from mitochondria normally contri-
butes to maintaining [Ca2+]ER [52]. A similar result was found in an
endothelial cell line, namely that inhibition of mitochondrial Ca2+
efﬂux prevented ER re-ﬁlling following a histamine challenge [53]. In
aortic smooth muscle cells, inhibiting the mNCX with CGP37157
impaired SR re-ﬁlling upon stimulation with ATP to activate
purinergic receptors [54]. A recent review has considered whether
the mNCX is also situated close enough to the ER to allow return of
mitochondrial Ca2+ directly into the ER and contribute to store-
reﬁlling in neuronal cells [55]. Whether the mNCX interacts with the
SR in the heart remains to be investigated.
2.4. Role of [Ca2+]m in energy production
In the heart there needs to be a way of rapidly producing ATP to
meet changes in energy demand, such as upon increased workload or
hormonal stimulation. Early studies in isolated mitochondria found
Fig. 3.Mitochondrial Ca2+ transport in excitation-contraction coupling. The routes of Ca2+ inﬂux and efﬂux during excitation-contraction coupling are shown, together with possible
interactions of the mitochondrial Ca2+ transport pathways with those of the SR and sarcolemma. In this model Ca2+ is shown enteringmitochondria directly from the RyRs or L-type
Ca2+ channels via mCU, and efﬂux from mNCX contributes to SR re-ﬁlling during relaxation. Efﬂux of Ca2+ from mitochondria near the sarcolemmal NCX is also shown, although
there is no experimental evidence as yet for such a mechanism. There is evidence for all the other interactions shown – see text for details. mCU - Ca2+-uniporter; mNCX –
mitochondrial Na+/Ca2+ exchanger; NCX – sarcolemmal Na+/Ca2+ exchanger; RyR – ryanodine receptor; SERCA – sarcoplasmic/endoplasmic reticular Ca2+-ATPase.
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however later studies in beating hearts found that the ratio does not
change in well-oxygenated hearts even during large increases in
workload [57,58]. In support of this, we found recently, using targeted
luciferase, that ATP levels in beating cardiomyocytes were remarkably
constant in both cytosolic and mitochondrial compartments [32].
In the 1970's and 1980's Denton and McCormack found that Ca2+
could activatemitochondrial dehydrogenases in thephysiological range;
K0.5 for both pyruvate dehydrogenase (PDH) and oxoglutarate dehy-
drogenase (OGDH) was around 1 μM, whereas that of isocitrate
dehydrogenase (ICDH) was higher, 5-50 μM, depending on the ATP/
ADP ratio [59]. This lead themtopropose that an increase in the supplyof
reducing equivalents in the formofNADHand FADHwould increaseATP
production; thus suggesting a parallel activationmodel of stimulation of
contraction andATP synthesis by Ca2+ [5,59]; see Fig. 4 for a summary of
the model. The mitochondrial F1F0ATP synthase (ATPase) may also be
stimulatedbyCa2+ [6,60]; bindingof Ca2+ to anATPase inhibitor protein
– IF1 – has been proposed[61,62], although there is little direct evidence
as to how this occurs. Recent evidence indicates a role for IF1 in
regulation of mitochondrial structure, for example IF1 overexpression
increases the density of cristae in the mitochondria, increases ATP
synthase activity, and protects against ischaemia/reperfusion injury
[63,64]. It therefore presents an attractive control point; however, how,
and indeed whether, it is regulated by Ca2+ is far from clear.Balaban [65]has argued that, given the importanceof ensuringa rapid
response system of ATP synthesis in the myocardium, more than one
mechanism is likely to operate to coordinate ATP supply and demand. To
illustrate this he quoted evidence showing that in a canine heart the
entire ATP pool is turned over in 1 min under normal conditions, and in
about 10 sec under conditions of high workload [65–67].
Upon increases in pacing frequency in freshly isolated rat
cardiomyocytes, form 0.2 Hz to 4 Hz (12 to 240 bpm), [Ca2+]m did
not increase, even though ATP demand would have increased
substantially under these conditions [23,33], and see Fig. 5. However,
upon addition of an adrenergic agonist, [Ca2+]m increased gradually,
over tens of seconds (Fig. 5). Similarly in beating guinea-pig hearts
perfused with 10 µM Ru360, which should inhibit Ca2+ uptake into
mitochondria, no effect on contractionwas observed [68]. This implies
that ATP levels were maintained even though no increase in [Ca2+]m
should have occurred. This again suggests that, whereas increases in
[Ca2+]m may play a role under conditions of increased workload,
under basal conditions there are alternative mechanisms coupling
ATP supply to demand. We found that in myocytes stimulated to beat
suddenly from rest, and under conditions of high external [Ca2+],
there was a drop in [ATP]m before it started to rise again, and this
exactly matched the time over which an increase in [Ca2+]m occurred
[32], and see Fig. 6. Very little change in [ATP]c occurred during this
time, conﬁrming that it is extremely well buffered [32].
Fig. 4. Mitochondrial Ca2+ - key role in regulation of energy supply and demand.
Increases in cytosolic Ca2+ are relayed to the mitochondrial matrix via the
mitochondrial Ca2+ uniporter (mCU). [Ca2+]m activates dehydrogenase of the citric
acid cycle and possibly the ATP synthase to increase ATP supply in line with the
increased demand. See text for further details.
Fig. 5. Changes in mitochondrial [Ca2+] during rapid stimulation of adult rat myocytes.
Myocytes were loaded with indo-1 under conditions that promote mitochondrial
localisation of the dye, and stimulated to contract rapidly (4 Hz) in absence or presence
of noradrenaline. Only a small increase in [Ca2+]m occurs upon rapid stimulation alone,
but a much larger increase occurs in presence of the adrenergic agonist. See text for
discussion; ﬁgure adapted form data ﬁrst presented in [33].
Fig. 6. Changes in [ATP]m and average [Ca2+]m in adult cardiomyocytes stimulated to beat
form rest. [Ca2+]m and [ATP]m were measured using targeted aequorin and luciferase,
respectively, in parallel experiments on small populations of cells stimulated to contract at
2 Hz from rest in presence of isoproterenol. In this ﬁgure the average [Ca2+]m is shown –
see text for discussion. Figure based on data ﬁrst published in [32].
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Saks and colleagues have put forward the idea that the subcellular
architecture changes during contraction, causing a decrease in the Km
of ADP for stimulating respiration, and removing diffusion limits of
ADP that occur in resting cells [69,70]. This requires the mitochondria
to be organised in structural units with ATP consuming processes in
the cell, such as myoﬁbrils, SR and sarcolemmal ATPases -so called
“intracellular energy units” - where channelling of ADP occurs [71–
73].
3. Developmental changes in mitochondria and Ca2+ handling
Changes in [Ca2+]m during development present an interesting
study since mitochondrial Ca2+ transients occur in neonatal but not
adult rat myocytes. How and why this occurs is not known, but there
are major metabolic and ionic changes occurring over this period.
During the ﬁrst weeks following birth the SR and surface membrane
system are underdeveloped. During the 7 to 14 day old period (in
rats), the surface membrane system rapidly increases in complexity
and surface area and the SR develops a honeycomb network around
the myoﬁbrils. By 3 weeks, all these structures have reached their
adult form [74].
In adults the crucial tight spatial and temporal coupling between
the RyRs and the L-type Ca2+ channels allows for Ca2+-induced Ca2+-
release, and the majority of Ca2+ used for contraction comes form the
SR. Neonates, however, are more reliant upon Ca2+ entry across the
sarcolemma for contraction [75,76], but the exact changes are species
dependent since some animals are more mature at birth than others
[77]. In adult heart muscle ryanodine completely abolished contractile
force, proving that the SR plays a major role in E-C coupling, but in
neonates ryanodine failed to abolish contraction completely [78].
Although the SR is less developed in neonates, it does appear to
contain a large store of Ca2+: caffeine-induced Ca2+ release in the
neonates was actually quite robust, suggesting that the SR is primed
with Ca2+ in the neonatal ventricularmyocytes, but, paradoxically it is
not released in response to electrical stimuli [79,80]. So although the
SR at birth may be capable of releasing Ca2+ in response to caffeine,
the scarcity of t-tubules functionally isolates the SR from taking part in
E-C coupling.
In neonatal myocytes, [Ca2+]c increased in the subcellular space
during each transient, followed by a smaller rise in the cell centre. Thisis in contrast to the uniform elevation and decline of whole cell Ca2+
transients that occurs in adult myocytes. The transition from the
neonatal to the adult pattern of Ca2+ transients coincides with the
appearance of a mature t-tubular network [79]. Immature myocytes
also relax more slowly than adult myocytes; disabling the SR did not
slow relaxation in the younger ages, as it did in the adults, suggesting
that the sarcolemmal NCX is the predominant pathway for the
removal of Ca2+ [79]. Mitochondria in neonatal myocytes appear to be
connected into a mitochondrial reticulum, rather than the
punctated appearance in adult cells (see Fig. 7). We do not yet
know the implications of this for control of energy metabolism in
neonates, neither have there been any studies on the interactions of
Fig. 7. Adult and neonatal rat cardiomyocytes showing distribution of mitochondria.
The image shows developmental changes in the distribution of mitochondria (using
mitotracker green) and also cell nuclei (stainedwith DAPI) in a neonatal (left) and adult
(right) cardiomyocyte (Balaska and Grifﬁths, unpublished data).
Fig. 8.Mechanism of NO-induced inhibition of MPTP opening in cardiomyocytes. There
is evidence from studies on single myocytes that NO form either exogenous or
endogenous sources can inhibit respiration, which would depolarise the mitochondrial
membrane potential. This in turn inhibits Ca2+ uptake by the Ca2+-uniporter, and
therefore reduces likelihood of the MPTP opening, resulting in cardioprotection.
Scheme based on data published in [98,107,108].
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in these cells.
There are also fewer mature mitochondria in the neonatal
myocytes and reduced facility for aerobic ATP production compared
with the adult; a dependence that lessens with age as mitochondrial
function matures and oxidative metabolism increases. The mitochon-
drial cristae of young myocytes are sparse and widely separated,
which indicates a lower amount of aerobic metabolism and the
number, volume and density of mitochondria is also lower in the
younger animals [81]. Mitochondrial volume occupies about 20% of
the cell volume in a one day old rat versus about 40% in an adult rat
[82]. The postnatal development of enzyme activities depends on the
degree of maturation of individual species at birth, for example, in the
rat (which is highly immature at birth) mitochondrial enzymes such
as citrate synthase and cytochrome c oxidase increase steadily from
the end of prenatal life up to adulthood [77]. The activity of creatine
kinase was also increased during development [83].
The question of whether Ca2+ plays a role in stimulating
respiration in neonatal hearts has not been addressed previously to
the best of our knowledge. In preliminary experiments we found that
respiration is stimulated by Ca2+ at non-saturating substrate levels in
mitochondria from neonatal hearts, as for adult hearts [84]. We have
also studied one of the dehydrogenases, OGDH, and found that there
are signiﬁcant differences compared with the adult: Km for its
substrate is reduced, and although Ca2+ acts to reduce Km, as in the
adult, this effect is even greater in the neonatal mitochondria [84].
How and why this occurs, and whether it also occurs for the other
dehydrogenases, is yet to be investigated.
4. Nitric oxide synthase and mitochondria
NO produced endogenously from nitric oxide synthases (eNOS,
iNOS and nNOS) is crucial for many physiological and pathological
processes in the heart [85–87]. Increasing evidence indicates that
mitochondria may be one site of action for the protective effects of NO
(reviewed in [88]); NO has been reported to inhibit the mitochondrial
permeability transition pore leading to less necrotic death in
ischaemia/reperfusion injury, and to prevent cytochrome c leading
to an inhibition of apoptosis [88]. Furthermore studies on isolated
mitochondria have revealed a potential role for NO in the regulation of
respiration and ATP synthesis [89,90].
Given the possible control of mitochondrial function by NO, the
existence of an isoform of NOS in mitochondria (mNOS) hasgenerated a lot of interest since it was ﬁrst proposed in 1995
[90,91]. However, there is signiﬁcant controversy in this area,
especially with regard to the likelihood of contamination of
“mitochondria” with other membrane fractions, such as sarcolemma
or SR, giving rise to false positive results for either presence of NOS, or
detection of NO (reviewed in [92]). Indeed in one study using
mitochondria isolated from human heart papillary muscle or from
mouse heart, western blotting with seven different NOS antibodies
failed to detect NOS in mitochondria [93]. We have also found no
evidence for the existence of NOS in puriﬁed heart or liver
mitochondria, using a variety antibodies against all known forms of
NOS (Cheng and Grifﬁths, unpublished data), and therefore conclude
that any regulation of mitochondrial function by NO must be arising
from NO released from a non-mitochondrial form of NOS. In
myocytes, nNOS has been detected in the SR [94–96] and reported
to regulate RyR function, probably by S-nitrosylation, and co-
precipitates with the RyR [95]. nNOS may therefore also be located
in close proximity tomitochondria in cardiomyocytes in situ, and so be
able to regulate mitochondrial function, particularly in view of
evidence (discussed above) indicating a close association between
mitochondria and the SR in membrane particles after isolation [43].
One proposed role of having NOS localised in or near mitochondria
is in modulation of mitochondrial Ca2+ uptake: Adding SNAP (an NO-
donor) to neonatal cardiomyocytes caused rapid inhibition of
respiration (as indicated by an increase in NADH ﬂuorescence), and
decreases in mitochondrial membrane potential (Δψm) and Ca2+
uptake [97]. In endothelial cells loaded with fura-2 and then
permeabilised to releases the cytosolic dye so that the signal
originated frommitochondria only, the NO-donor spermine-NONOate
decreased Δψm (TMRE ﬂuorescence) and also reduced accumulation
of added Ca2+ by mitochondria [98]. This reduction of Ca2+
accumulation by NO is themechanismwhereby NO has been reported
to delay opening of the MPTP, as seen in a model of oxidative stress in
isolated cardiomyocytes [99], and see Fig. 8.
862 E.J. Grifﬁths et al. / Biochimica et Biophysica Acta 1797 (2010) 856–864A physiological role of NO inmodulatingmitochondrial Ca2+ is less
obvious, however, since normally O2 would out-compete NO for
binding to cytochrome c oxidase. Increases in [Ca2+] in the
physiological range (about 0.2 µM) can activate eNOS and nNOS,
located in or near mitochondria. This would then lower [Ca2+]m by
decreasing Δψm, and tend to inhibit activation of the mitochondrial
dehydrogenases by Ca2+ [59]. Ca2+ would therefore have dual and
opposing effects on ATP synthesis, as suggested by Giulivi et al. [100],
giving a complex interplay whereby Ca2+both stimulates and inhibits
respiration. Under conditions such as hypoxia, or high altitude
adaptation the role of NO may become more important since it will
be able to out-compete oxygen for binding to cytochrome c oxidase,
and therefore be able to limit mitochondrial Ca2+ uptake and MPTP
opening[99].5. Conclusions and implications for cardiac disease
[Ca2+]m plays an important role in both myocardial energy
production and intracellular Ca2+ signalling. However, there is likely
to be more than one mechanism coupling ATP supply and demand in
the heart; and the alternative mechanisms may operate under
different conditions: for example under basal conditions regulation
of respiration by channelling of ADP, themetabolic compartmentation
model, may be the dominant one, but upon large changes in workload,
when systolic [Ca2+]c increases, parallel activation of mitochondrial
metabolism ensures a greater, rapid, production of ATP. These
processes may have evolved to ensure that three are sufﬁcient backup
mechanism to ensure that the ATP supply does not fail.
Both mCU and mNCX have been proposed as possible targets for
cardioprotective drugs. A full discussion is beyond the scope of this
review.However, protectiveeffects ofRuRhavebeen found in ischaemia
reperfusion injury [101,102], although it is not certain that the drugwas
acting onmCU since it is not speciﬁc and also affects SR Ca2+ ﬂux [103].
Indeed we found, using a myocyte model of hypoxia/reoxygenation
injury, that RuR was not protective[104], however, in the same model
inhibiting the mNCX with clonazepam was protective. We concluded
that the route of Ca2+ entry intomitochondria underhypoxic conditions
is likely to be the mNCX rather than mCU [27,104].
The mNCX has also been considered a target for cardioprotection
in other recent studies: [Na+]i is increased during ischaemia/
reperfusion injury, and in heart failure (see [105] for a recent review
on regulation of [Na+]i). Recent work from O'Rourke's group has
shown that dysregulation of Na+ homeostasis in heart failure may be
a primary cause of mitochondrial dysfunction: in a guinea-pig model
of heart failure (induced by aortic constriction), intracellular [Na+]
was 16 mM compared with 5 mM in control cells [13]. Rapid pacing of
the cells induced a decrease in NADH ﬂuorescence, an indirect
indicator of respiratory chain activity, whereas this was maintained in
controls. CGP 37157, an inhibitor of mNCX, was able to prevent the
decrease in NADH in the failing myocytes. It is thus likely to restore
ATP levels: earlier work showed that the mNCX is capable of
regulating [Ca2+]m and dehydrogenase activity since adding Na+ to
isolated mitochondria shifts the activation curves for PDH and OGDH
by Ca2+ to the right [106].
A great deal of progress has been made in elucidating the roles of
[Ca2+]m in the heart with the development of ﬂuorescent indicators
and now ﬂuorescent proteins targeted to the mitochondrial matrix,
together with advances in imaging technology. There is now evidence
for interactions between mitochondria and SR from both imaging
studies of subcellular architecture plus dynamic studies using
inhibitors of the SR and mitochondrial transport pathways, and the
precise role of [Ca2+]m in cell signalling and energy production is
becoming clearer, although not yet resolved. However, the biggest
limitation currently is the lack of identiﬁcation of the mitochondrial
Ca2+ transporters.Acknowledgements
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